Phase I study of paclitaxel and uracil plus tegafur combination in patients with pretreated metastatic breast cancer: drug sequencing based on preclinical modelling studies.

Passardi, A; Maltoni, R; Milandri, C; Cecconetto, L; Massa, I; Zoli, W; Tesei, A; Fabbri, F; Nanni, O; Amadori, D

Passardi, A; Maltoni, R; Milandri, C; Cecconetto, L; Massa, I; Zoli, W; Tesei, A; Fabbri, F; Nanni, O; Amadori, D.

Affiliation

Passardi A; Department of Medical Oncology, Morgagni-Pierantoni Hospital, Forlì, Italy. sandropass@libero.it

Oncology ; 72(1-2): 118-24, 2007.

Article in En | MEDLINE | ID: mdl-18004083

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/adverse effects; Breast Neoplasms/drug therapy; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Breast Neoplasms/pathology; Cell Line, Tumor; Drug Administration Schedule; Drug Screening Assays, Antitumor; Female; Humans; Leucovorin/administration & dosage; Maximum Tolerated Dose; Middle Aged; Models, Theoretical; Neoplasm Metastasis; Paclitaxel/administration & dosage; Tegafur/administration & dosage; Uracil/administration & dosage

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Oncology Year: 2007 Document type: Article Affiliation country: Italy Country of publication: Switzerland

Search on Google

Add to My VHL

XML

PubMed Links